The EANM guideline on radioiodine therapy of benign thyroid disease

DSpace/Manakin Repository

The EANM guideline on radioiodine therapy of benign thyroid disease
 
Campennì, Alfredo; Avram, Anca M.; Verburg, Frederik A.; Iakovou, Ioannis; Hänscheid, Heribert; de Keizer, Bart; Petranović Ovčariček, Petra; Giovanella, Luca
(2023) European Journal of Nuclear Medicine and Molecular Imaging, volume 50, issue 11, pp. 3324 - 3348
(Article)
Abstract
This document provides the new EANM guideline on radioiodine therapy of benign thyroid disease. Its aim is to guide nuclear medicine physicians, endocrinologists, and practitioners in the selection of patients for radioiodine therapy. Its recommendations on patients’ preparation, empiric and dosimetric therapeutic approaches, applied radioiodine activity, radiation protection requirements, and patients follow-up after administration ... read more
Download/Full Text
Open Access version via Utrecht University Repository Publisher version
Version on publisher website for UU-students and staff
Version on publisher website
 
Keywords: Dosimetry, Fixed activity, Graves’ disease, Non-toxic goiter, RAI therapy, Toxic nodular goiter, Radiology Nuclear Medicine and imaging
DOI: https://doi.org/10.1007/s00259-023-06274-5
ISSN: 1619-7070
Publisher: Springer-Verlag
Note: Funding Information: The guidelines were brought to the attention of the relevant EANM Committees and the National Societies of Nuclear Medicine. The comments and suggestions from the EANM [Physics Committee, Dosimetry Committee, Radiation Protection Committee, Radiopharmaceutical Sciences Committee, Oncology & Theranostics Committee, Paediatrics Committee, Technologist Committee] and the Austrian, Slovak, Italian, Dutch, Serbian, Hellenic, Romanian, Turkish, Latvian, Estonian, Polish, Danish, Hungarian, British, French, North Macedonia, and Belgian National Societies are highly appreciated and have been considered for this Guideline. Publisher Copyright: © 2023, The Author(s).
(Peer reviewed)